Tag Archive: Company News
Oncimmune announces strategy updates and changes to the board of directors.
October 12, 2023 12:33 pm
Oncimmune receives Queen’s Award for Enterprise in Innovation 2022
April 21, 2022 9:02 am
Oncimmune signs contracts with US-based clinical-stage biopharmaceutical companies developing immunotherapies one of which is focused on CAR NK cell therapies.
April 8, 2022 9:06 am
Follow-on contract signed with leading US medical research organisation, to validate previous profiling in COVID-19
March 7, 2022 10:15 am
ImmunoINSIGHTS signs contract with leading top 10 global pharmaceutical company to profile biomarkers in Chronic Inflammatory Demyelinating Polyradiculoneuropathy (“CIDP”).
March 4, 2022 10:17 am
ImmunoINSIGHTS and Synexa Life Sciences sign go-to-market service partnership
March 1, 2022 10:22 am